Jeil Pharmaceutical Co.,Ltd (KRX:271980)

KRX:271980 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	206,624	220,758	166,115	249,173	306,002	494,458
Market Cap Growth	6.86%	32.90%	-33.33%	-18.57%	-38.11%	-45.95%
Enterprise Value	281,163	296,796	219,930	307,855	346,161	503,450
Last Close Price	14180.00	15150.00	11400.00	17100.00	20937.61	33666.10
PE Ratio	8.83	9.44	-	49.79	-	-
PS Ratio	0.36	0.39	0.24	0.34	0.42	0.71
PB Ratio	0.82	0.88	0.76	1.46	1.87	2.96
P/TBV Ratio	1.02	1.09	0.91	1.62	1.99	3.01
P/FCF Ratio	-	-	-	-	-	35.94
P/OCF Ratio	-	-	51.70	-	-	25.89
EV/Sales Ratio	0.50	0.52	0.31	0.42	0.48	0.72
EV/EBITDA Ratio	8.44	8.91	-	16.50	-	-
EV/EBIT Ratio	13.39	14.14	-	34.64	-	-
EV/FCF Ratio	-20.49	-	-	-	-	36.60
Debt / Equity Ratio	0.37	0.37	0.35	0.42	0.33	0.29
Debt / EBITDA Ratio	2.80	2.80	-	3.82	-	-
Debt / FCF Ratio	-	-	-	-	-	3.48
Net Debt / Equity Ratio	0.14	0.14	0.08	0.21	0.14	0.12
Net Debt / EBITDA Ratio	1.04	1.04	-2.51	1.90	-5.12	-15.87
Net Debt / FCF Ratio	-2.52	-2.52	-17.13	-3.21	-0.87	1.44
Asset Turnover	1.10	1.10	1.39	1.54	1.64	1.68
Inventory Turnover	3.39	3.39	4.92	5.19	5.61	5.15
Quick Ratio	0.82	0.82	0.79	0.66	0.71	0.78
Current Ratio	1.29	1.29	1.18	1.04	1.12	1.28
Return on Equity (ROE)	13.61%	13.61%	-15.45%	3.11%	-9.06%	-8.82%
Return on Assets (ROA)	2.53%	2.53%	-2.29%	1.18%	-1.89%	-1.55%
Return on Invested Capital (ROIC)	6.79%	7.35%	-8.36%	4.52%	-7.13%	-5.16%
Return on Capital Employed (ROCE)	7.80%	7.80%	-7.90%	4.90%	-6.80%	-5.10%
Earnings Yield	11.32%	10.59%	-18.04%	2.01%	-4.28%	-2.52%
FCF Yield	-6.64%	-6.22%	-0.64%	-4.45%	-8.57%	2.78%
Dividend Yield	-	-	-	0.29%	0.24%	-
Payout Ratio	-	-	-	14.55%	-	-
Buyback Yield / Dilution	-0.01%	-0.01%	0.02%	0.02%	0.23%	0.04%
Total Shareholder Return	-0.01%	-0.01%	0.02%	0.31%	0.47%	0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.